Blood manganese levels in patients with hepatic encephalopathy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Trace Elements in Medicine and Biology

• Publication date

  2011-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.jtemb.2011.07.003PMID 21975221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms.

  2011cited by this paper
• Effects of chronic manganese exposure on working memory in non-human primates.

  2009cited by this paper
• Magnetic Resonance Imaging of Brain in Patients with Cirrhotic and Non-Cirrhotic Portal Hypertension

  2008cited by this paper
• Biomarkers of manganese exposure in a population living close to a mine and mineral processing plant in Mexico.

  2008cited by this paper
• The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.

  2008cited by this paper
• MR Imaging Findings in Hepatic Encephalopathy

  2008cited by this paper
• Liver transplantation in a patient with rapid onset parkinsonism-dementia complex induced by manganism secondary to liver failure.

  2007cited by this paper
• Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects.

  2007cited by this paper
• Hepatic encephalopathy as a predictor of survival in patients with end‐stage liver disease

  2007cited by this paper
• Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal.

  2007cited by this paper
• Manganese: recent advances in understanding its transport and neurotoxicity.

  2007cited by this paper
• High signal intensity on magnetic resonance imaging as a predictor of neurobehavioral performance of workers exposed to manganese.

  2007cited by this paper
• The Neuropathology of Manganese-Induced Parkinsonism

  2007cited by this paper
• The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy

  2007cited by this paper
• Higher Prevalence and Severity of Hepatic Encephalopathy in Patients with HCV Cirrhosis and Diabetes Mellitus: Is Presence of Autonomic Neuropathy the Missing Part of the Puzzle?

  2006cited by this paper
• Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.

  2006cited by this paper
• The brain glutamate system in liver failure

  2006cited by this paper
• The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation.

  2006cited by this paper
• Neurological complications of liver cirrhosis and orthotopic liver transplant.

  2006cited by this paper
• Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.

  2006cited by this paper
• Application of pharmacokinetic data to the risk assessment of inhaled manganese.

  2006cited by this paper
• Nutritional status and prognosis in cirrhotic patients

  2006cited by this paper
• Parkinsonism due to manganism in a welder: neurological and neuropsychological sequelae.

  2006cited by this paper
• Motor alterations associated with exposure to manganese in the environment in Mexico.

  2006cited by this paper
• Hepatic Encephalopathy: From Pathophysiology to Treatment

  2006cited by this paper
• Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis.

  2005cited by this paper
• Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.

  2005cited by this paper
• [Alcoholism during pregnancy: an underestimated health problem].

  2004cited by this paper
• Pathophysiology of Hepatic Encephalopathy: A New Look at GABA from the Molecular Standpoint

  2004cited by this paper
• Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

  2003cited by this paper
• Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes

  2002cited by this paper
• 1H Magnetic Resonance in the Study of Hepatic Encephalopathy in Humans

  2002cited by this paper
• MELD: the end of Child-Pugh classification?

  2002cited by this paper
• Predicting the prognosis of chronic liver disease: An evolution from child to MELD

  2001cited by this paper
• Complications of cirrhosis III. Hepatic encephalopathy.

  2000cited by this paper
• Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the 'peripheral-type' benzodiazepine receptor ligand 3H-PK 11195.

  1999cited by this paper
• Bioindicator and exposure data for a population based study of manganese.

  1999cited by this paper
• Manganese neurotoxicity: a review of clinical features, imaging and pathology.

  1999cited by this paper
• Role of Manganese in the Pathogenesis of Portal-Systemic Encephalopathy

  1998cited by this paper
• Early manifestations of manganese neurotoxicity in humans: an update.

  1997cited by this paper
• Manganese and chronic hepatic encephalopathy.

  1995cited by this paper
• Symptomatic manganese neurotoxicity in a patient with chronic liver disease: correlation of clinical symptoms with MRI findings.

  1994cited by this paper
• Possible health effects of high manganese concentration in drinking water.

  1989cited by this paper
• Catecholamine toxicity : a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease

  1984cited by this paper
• Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.

  1984cited by this paper
• Determination of manganese in whole blood and serum.

  1980cited by this paper

• Targeting immune checkpoint therapy: The role of manganese in tumor immunotherapy.

  2025cites this paper
• Gut microbiome-brain-cirrhosis axis.

  2023cites this paper
• Hepatic encephalopathy on magnetic resonance imaging and its uncertain differential diagnoses: a narrative review

  2023cites this paper
• The association between blood manganese and liver stiffness in participants with chronic obstructive pulmonary disease: a cross-sectional study from NHANES 2017–2018

  2023cites this paper
• Biodegradable MnO-Based Nanoparticles with Engineering Surface for Tumor Therapy: Simultaneous Fenton-Like Ion Delivery and Immune Activation.

  2022cites this paper
• The meningeal lymphatic vasculature in neuroinflammation

  2022cites this paper
• Manganese

  2022cites this paper
• Inherited Manganese Disorders and the Brain: What Neurologists Need to Know

  2021cites this paper
• High manganese exposure decreased the risk of high triglycerides in workers: a cross-sectional study

  2020cites this paper
• Manganese

  2020cites this paper
• The impact of manganese on neurotransmitter systems.

  2020cites this paper
• Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment

  2019cites this paper
• Influence of iron metabolism on manganese transport and toxicity.

  2017cites this paper
• Maternal and Cord Blood Manganese Concentrations and Early Childhood Neurodevelopment among Residents near a Mining-Impacted Superfund Site

  2017cites this paper
• iTRAQ-based proteomic technology revealed protein perturbations in intestinal mucosa from manganese exposure in rat models

  2017cites this paper
• Glutamine triggers long‐lasting increase in striatal network activity in vitro

  2017cites this paper
• Reactive Nitrogen and Oxygen Species in Hepatic Encephalopathy

  2017cites this paper
• Higher Grades and Repeated Recurrence of Hepatic Encephalopathy May Be Related to High Serum Manganese Levels

  2016cites this paper
• Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy

  2016cites this paper
• SLC30A10: A novel manganese transporter

  2015cites this paper
• Manganese homeostasis in the nervous system

  2015cites this paper
• Gene-Environment Interactions Between Manganese Toxicity and Early-Onset Parkinson's Disease Genes

  2015cites this paper
• Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

  2015cites this paper
• Manganese-induced Neurotoxicity: From C. elegans to Humans.

  2015cites this paper
• Manganese Is Essential for Neuronal Health.

  2015cites this paper
• Efficacy and tolerability of rifaximin in combination with lactulose in end-stage liver disease patients with MELD greater than 20: a single center experience.

  2014cites this paper
• Optimal oxygen saturations in preterm infants: a moving target

  2013cites this paper
• Vasoactive Substances and Inflammatory Factors in Progression of Liver Cirrhosis with Portal Hypertension

  2013cites this paper
• Therapeutic efficacy of silymarin from milk thistle in reducing manganese-induced hepatic damage and apoptosis in rats

  2013cites this paper